These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9658134)

  • 41. The antiviral activity of HIV-specific CD8+ CTL clones is limited by elimination due to encounter with HIV-infected targets.
    McKinney DM; Lewinsohn DA; Riddell SR; Greenberg PD; Mosier DE
    J Immunol; 1999 Jul; 163(2):861-7. PubMed ID: 10395680
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of major histocompatibility complex class I/peptide/beta2M tetramers to quantitate CD8(+) cytotoxic T lymphocytes specific for dominant and nondominant viral epitopes in simian-human immunodeficiency virus-infected rhesus monkeys.
    Egan MA; Kuroda MJ; Voss G; Schmitz JE; Charini WA; Lord CI; Forman MA; Letvin NL
    J Virol; 1999 Jul; 73(7):5466-72. PubMed ID: 10364294
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recognition of a highly conserved region of human immunodeficiency virus type 1 gp120 by an HLA-Cw4-restricted cytotoxic T-lymphocyte clone.
    Johnson RP; Trocha A; Buchanan TM; Walker BD
    J Virol; 1993 Jan; 67(1):438-45. PubMed ID: 7677956
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual.
    Harrer T; Harrer E; Barbosa P; Kaufmann F; Wagner R; Brüggemann S; Kalden JR; Feinberg M; Johnson RP; Buchbinder S; Walker BD
    J Immunol; 1998 Nov; 161(9):4875-81. PubMed ID: 9794421
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impacts of epitope expression kinetics and class I downregulation on the antiviral activity of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes.
    Ali A; Lubong R; Ng H; Brooks DG; Zack JA; Yang OO
    J Virol; 2004 Jan; 78(2):561-7. PubMed ID: 14694087
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Specific lysis of human immunodeficiency virus type 1-infected cells by a HLA-A3.1-restricted CD8+ cytotoxic T-lymphocyte clone that recognizes a conserved peptide sequence within the gp41 subunit of the envelope protein.
    Takahashi K; Dai LC; Fuerst TR; Biddison WE; Earl PL; Moss B; Ennis FA
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10277-81. PubMed ID: 1719555
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine.
    Johnson RP; Hammond SA; Trocha A; Siliciano RF; Walker BD
    J Virol; 1994 May; 68(5):3145-53. PubMed ID: 7908700
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.
    Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL
    J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Studies of the mechanism of cytolysis by HIV-1-specific CD4+ human CTL clones induced by candidate AIDS vaccines.
    Miskovsky EP; Liu AY; Pavlat W; Viveen R; Stanhope PE; Finzi D; Fox WM; Hruban RH; Podack ER; Siliciano RF
    J Immunol; 1994 Sep; 153(6):2787-99. PubMed ID: 7915742
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selection and accumulation of an HIV-1 escape mutant by three types of HIV-1-specific cytotoxic T lymphocytes recognizing wild-type and/or escape mutant epitopes.
    Akahoshi T; Chikata T; Tamura Y; Gatanaga H; Oka S; Takiguchi M
    J Virol; 2012 Feb; 86(4):1971-81. PubMed ID: 22156528
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gene combination raises broad human immunodeficiency virus-specific cytotoxicity.
    Calarota SA; Kjerrström A; Islam KB; Wahren B
    Hum Gene Ther; 2001 Sep; 12(13):1623-37. PubMed ID: 11535166
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lysis of CD4+ T cells expressing HIV-1 gag peptides by gag-specific CD8+ cytotoxic T cells.
    Salerno-Gonçalves R; Lu W; Achour A; Andrieu JM
    Immunol Lett; 1998 Dec; 64(2-3):71-7. PubMed ID: 9870657
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
    Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Different Effects of Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations on Cytotoxic T Lymphocyte Recognition between HIV-1 Subtype B and Subtype A/E Infections.
    Kuse N; Rahman MA; Murakoshi H; Tran GV; Chikata T; Koyanagi M; Nguyen KV; Gatanaga H; Oka S; Takiguchi M
    J Virol; 2015 Jul; 89(14):7363-72. PubMed ID: 25972553
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi.
    Rowland-Jones SL; Dong T; Fowke KR; Kimani J; Krausa P; Newell H; Blanchard T; Ariyoshi K; Oyugi J; Ngugi E; Bwayo J; MacDonald KS; McMichael AJ; Plummer FA
    J Clin Invest; 1998 Nov; 102(9):1758-65. PubMed ID: 9802890
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Naturally selected rilpivirine-resistant HIV-1 variants by host cellular immunity.
    Gatanaga H; Murakoshi H; Hachiya A; Hayashida T; Chikata T; Ode H; Tsuchiya K; Sugiura W; Takiguchi M; Oka S
    Clin Infect Dis; 2013 Oct; 57(7):1051-5. PubMed ID: 23797286
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Macrophage tropism of human immunodeficiency virus type 1 facilitates in vivo escape from cytotoxic T-lymphocyte pressure.
    Schutten M; van Baalen CA; Guillon C; Huisman RC; Boers PH; Sintnicolaas K; Gruters RA; Osterhaus AD
    J Virol; 2001 Mar; 75(6):2706-9. PubMed ID: 11222694
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response.
    Jones NA; Wei X; Flower DR; Wong M; Michor F; Saag MS; Hahn BH; Nowak MA; Shaw GM; Borrow P
    J Exp Med; 2004 Nov; 200(10):1243-56. PubMed ID: 15545352
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selection of TI8-8V mutant associated with long-term control of HIV-1 by cross-reactive HLA-B*51:01-restricted cytotoxic T cells.
    Kuse N; Akahoshi T; Gatanaga H; Ueno T; Oka S; Takiguchi M
    J Immunol; 2014 Nov; 193(10):4814-22. PubMed ID: 25305317
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Virus-specific cytotoxic T lymphocyte responses in patients infected with the human immunodeficiency virus, HIV-1.
    Rivière Y
    Cell Mol Biol (Noisy-le-grand); 1994; 40 Suppl 1():45-8. PubMed ID: 7950861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.